New York, New York — According to state and local development sources, Axsome Therapeutics plans to build out 96,000 square feet of new space in New York. The company plans to occupy the new space in New York, on or about December 1, 2025. According to the company website Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.

To learn more about Axsome Therapeutics, visit http://www.axsome.com/

Company Contact:
Herriot Tabuteau, Chief Executive Officer
212-332-3241

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.